Position in REGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$3,486,212
-$5,938,588 QoQ
Shares Held
5,591
-68.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#428
of 1,320 holders
Holding Since
Sep 2021
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Derivatives in REGN
reported options exposure · as of Sep 30, 2021CallValue
$23,178,394
CallShares
38,300
PutValue
$25,236,006
PutShares
41,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026IMC-Chicago, LLC holds $54,107,382 across 30 Biotechnology names. REGN ranks #5 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
87,392 | $11,645,857 | |
| 2 | INSM |
INSMED Inc
|
76,126 | $8,116,554 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
10,847 | $5,824,296 | |
| 4 | CELC |
Celcuity Inc.
|
41,127 | $4,302,706 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
5,591 | $3,486,212 | |
| 6 | BNTX |
BioNTech SE
|
29,282 | $2,724,690 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
10,187 | $2,493,471 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
68,630 | $2,428,815 |
All Filings in REGN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,486,212 | 5,591 | Shares | Sole | 2026-08-06 | |
| 2025-06-30 | $9,424,800 | 17,952 | Shares | Sole | 2025-07-22 | |
| 2021-09-30 | $25,236,006 | 41,700 | Put | Sole | 2021-11-05 | |
| 2021-09-30 | $23,178,394 | 38,300 | Call | Sole | 2021-11-05 | |
| No filing history on record for this holder in this stock. | ||||||